Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini
NCT ID: NCT03746548
Last Updated: 2020-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2018-01-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Audiological Benefit and Improved Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Bonebridge in Experienced Users
NCT03766152
Quality of Life With Bone Conduction Hearing Device
NCT03864731
Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband
NCT03541967
Audiological Benefit With Non-implantable Bone Conduction Hearing Systems
NCT03129191
Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss
NCT03327194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Audiologic testing will consist of free field audiometry, Freiburger monosyllables test and Oldenburg sentence test. All tests will be performed with and without the devices.
Quality of life and hearing related questionnaires will consist of the AQoL-8D and the SSQ12.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CM-ADHEAR
First patients use the Contact Mini (conventional bone conduction device used with a soft band or headband) then ADHEAR (adhesive bone conduction device)
Adhear
Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks
Contact Mini (CM)
Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks
ADHEAR - CM
First patients use ADHEAR (adhesive bone conduction device) then CM (conventional bone conduction device used with a soft band or headband)
Adhear
Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks
Contact Mini (CM)
Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adhear
Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks
Contact Mini (CM)
Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The bone conduction threshold for the patient's affected ear shall be better than or equal to 25 dB HL (PTA BC for 0.5, 1, 2, 3 kHz).
* Subjects aged 13 years or older
* Capable of the German language
* Willingness and ability to perform all tests required for the study
* Signed, and dated informed consent before the start of any study specific procedure
Exclusion Criteria
* Patient is intolerant of the materials as described by Manufacturer's IFU
* Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
* Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
* Patient presents with retrocochlear, or central auditory disorder.
* any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures
13 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dominik Riss
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dominik Riss
Assoc. Prof. PD. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MUW AKH
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1573/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.